SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 416.74+1.2%Dec 26 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
maceng2
pak73
sense
To: maceng2 who wrote (175648)8/2/2021 12:49:14 PM
From: ggersh3 Recommendations  Read Replies (3) of 218800
 
wallstreetonparade.com

As of its most recent July 27 update on COVID vaccines, the Centers for Disease Control and Prevention (CDC) in the United States carries this statement:

“Infections happen in only a small proportion of people who are fully vaccinated, even with the Delta variant.”

That statement stands in stark contrast to what the Director of Public Health Services in Israel told television viewers of the CBS program, Face the Nation, on Sunday, reporting that 50 percent of new infections in Israel are from fully vaccinated people.

The Pfizer–BioNTech mRNA COVID-19 vaccine was the exclusive vaccine used to inoculate the broad population of Israel. It was also one of the two most highly-administered vaccines in the United States, with Moderna’s mRNA vaccine being the other. As of July 12, only 12.8 million people in the U.S. had been vaccinated with the Johnson & Johnson single-dose vaccine versus 146 million people in the U.S. that were fully vaccinated with either the Pfizer-BioNTech or Moderna vaccines, both of which require two doses.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext